Request an Appointment:
Online or Call 1-888-824-0200

Cutaneous Lymphoma Center at the University of Chicago Medicine

Cutaneous Lymphoma Team University of Chicago Medicine

The University of Chicago Medicine Cutaneous Lymphoma Center (UCMCLC) provides integrated, personalized care for patients with cutaneous lymphoma. Our clinicians use state-of-the-art technology and actively participate in research to improve our patients’ quality of life, allowing regional, national and international physicians to feel confident in referring their patients to our center.

Multidisciplinary Team of Experts

Due to its complexity, cutaneous lymphoma often involves care from a diverse team of specialists, including:

  • Dermatology
  • Oncology
  • Radiation Oncology
  • Transplant Oncology
  • Pathology: dermatopathology, hematopathology, molecular pathology


We understand that diagnosing cutaneous lymphoma can be a confusing and often frustrating process for patients. Our center’s dedication to integrated care means our physicians work together to identify your condition and develop an individual, efficient treatment plan for you. Our vast experience allows us to collaboratively guide our patients through their journey.

Research and Technology

University of Chicago Medicine Cutaneous Lymphoma Clinical Trials

Our center is committed to offering patients better treatment options. Scientific research and investigation increases our understanding of how to diagnose, treat and prevent lymphoma, and with access to state-of-the-art histochemical and molecular tools, our clinicians are able to effectively improve patient care. UCMCLC actively participates in ongoing research at the University of Chicago’s Lymphoma Biobank—an innovative program that studies bio specimens in an effort to connect personal and medical information. Our goal is to better understand how malignant lymphoma spreads and how it can be controlled.

Clinical Trials

As a leader in new cutaneous lymphoma therapies, the UCMCLC participates in relevant clinical trials. Conducted under rigorous guidelines, these trials help us determine the benefits and risks of new and existing therapies. They also offer our patients innovative treatments that are not widely available. If you are interested in participating in a clinical trial, talk with your physician about whether you’d be a good fit for the available trials.

Below you will find information about the current clinical trials taking place at the UCMCLC:

  1. A PROspective, Observational, US-based Study Assessing Outcomes, Adverse Events, Treatment Patterns, and Quality of Life in Patients Diagnosed with Mycosis Fungoides Cutaneous T-cell Lymphoma and Treated With Valcolr PROVe
  2. A Double Blind Randomized Vehicle Controlled Crossover Study to Evaluate the Safety and Efficacy of Topical Naloxone Hydrochloride Lotion 0.5% for the Relief of Pruritus in Patients with the MF Form of Cutaneous T-Cell Lymphoma (CTCL).
  3. A Phase 3 Multicenter, Randomized, Double-Blind, Placebo Controlled Study to Determine the Efficacy of Topical SGX301 (Synthetic Hypericin) and Fluorescent Bulb-Light Irradiation for the Treatment of Cutaneous T-Cell Lymphoma.

Additional Resources

Cutaneous Lymphoma Foundation
Leukemia Lymphoma Society
Lymphoma Research Foundation
National Comprehensive Cancer Network


Request an Appointment

Related Links

Online Library

Cutaneous T-Cell Lymphoma
Non-Hodgkin Lymphoma